JP2008537486A - 膜貫通タンパク質をコード化するヒトの自閉症感受性遺伝子およびその使用 - Google Patents

膜貫通タンパク質をコード化するヒトの自閉症感受性遺伝子およびその使用 Download PDF

Info

Publication number
JP2008537486A
JP2008537486A JP2008502516A JP2008502516A JP2008537486A JP 2008537486 A JP2008537486 A JP 2008537486A JP 2008502516 A JP2008502516 A JP 2008502516A JP 2008502516 A JP2008502516 A JP 2008502516A JP 2008537486 A JP2008537486 A JP 2008537486A
Authority
JP
Japan
Prior art keywords
autism
atp2b2
disorder
gene
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008502516A
Other languages
English (en)
Japanese (ja)
Inventor
フィリッピ，アン
ルソー，フランシス
ロシュマン，エルケ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IntegraGen SA
Original Assignee
IntegraGen SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IntegraGen SA filed Critical IntegraGen SA
Publication of JP2008537486A publication Critical patent/JP2008537486A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP2008502516A 2005-03-24 2006-03-23 膜貫通タンパク質をコード化するヒトの自閉症感受性遺伝子およびその使用 Pending JP2008537486A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66469705P 2005-03-24 2005-03-24
PCT/IB2006/001219 WO2006100608A2 (fr) 2005-03-24 2006-03-23 Gene humain de susceptibilite a l'autisme codant une proteine transmembrane et ses utilisations

Publications (1)

Publication Number Publication Date
JP2008537486A true JP2008537486A (ja) 2008-09-18

Family

ID=37024209

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008502516A Pending JP2008537486A (ja) 2005-03-24 2006-03-23 膜貫通タンパク質をコード化するヒトの自閉症感受性遺伝子およびその使用

Country Status (11)

Country Link
US (1) US20090215040A1 (fr)
EP (1) EP1863937B1 (fr)
JP (1) JP2008537486A (fr)
AT (1) ATE482290T1 (fr)
AU (1) AU2006225995B2 (fr)
CA (1) CA2601311A1 (fr)
DE (1) DE602006017045D1 (fr)
DK (1) DK1863937T3 (fr)
ES (1) ES2350851T3 (fr)
IL (1) IL185868A0 (fr)
WO (1) WO2006100608A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110091899A1 (en) * 2008-06-12 2011-04-21 Integragen Combination of risk alleles associated with autism
CA2726080A1 (fr) * 2008-06-12 2009-12-17 Integragen Procede de prevision de l'autisme
WO2011067296A1 (fr) 2009-12-01 2011-06-09 Integragen Combinaison de huit allèles à risque associés à l'autisme
EP2566977A1 (fr) 2010-05-04 2013-03-13 Integragen Nouvelle combinaison de huit allèles à risque associés à l'autisme

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030096264A1 (en) * 2001-06-18 2003-05-22 Psychiatric Genomics, Inc. Multi-parameter high throughput screening assays (MPHTS)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861719A (en) 1986-04-25 1989-08-29 Fred Hutchinson Cancer Research Center DNA constructs for retrovirus packaging cell lines
US5278056A (en) 1988-02-05 1994-01-11 The Trustees Of Columbia University In The City Of New York Retroviral packaging cell lines and process of using same
US5670488A (en) 1992-12-03 1997-09-23 Genzyme Corporation Adenovirus vector for gene therapy
CA2156725A1 (fr) 1993-02-22 1994-09-01 Warren S. Pear Production de retrovirus sans auxiliaire, a haut titre, par transfection transitoire
FR2712812B1 (fr) 1993-11-23 1996-02-09 Centre Nat Rech Scient Composition pour la production de produits thérapeutiques in vivo.
IL116816A (en) 1995-01-20 2003-05-29 Rhone Poulenc Rorer Sa Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
DE19911130A1 (de) * 1999-03-12 2000-09-21 Hager Joerg Verfahren zur Identifikation chromosomaler Regionen und Gene
EP1554403A1 (fr) * 2002-10-10 2005-07-20 K.U. Leuven Research and Development Gene de l'autisme
JP2008504838A (ja) * 2004-07-01 2008-02-21 アンテグラジャン Ｐｒｋｃｂ１をコードするヒト自閉症感受性遺伝子およびその使用

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030096264A1 (en) * 2001-06-18 2003-05-22 Psychiatric Genomics, Inc. Multi-parameter high throughput screening assays (MPHTS)

Also Published As

Publication number Publication date
ES2350851T3 (es) 2011-01-27
EP1863937A2 (fr) 2007-12-12
US20090215040A1 (en) 2009-08-27
DK1863937T3 (da) 2010-12-13
IL185868A0 (en) 2008-01-06
AU2006225995A1 (en) 2006-09-28
AU2006225995B2 (en) 2011-03-17
CA2601311A1 (fr) 2006-09-28
ATE482290T1 (de) 2010-10-15
DE602006017045D1 (de) 2010-11-04
WO2006100608A3 (fr) 2007-04-05
WO2006100608A2 (fr) 2006-09-28
EP1863937B1 (fr) 2010-09-22

Similar Documents

Publication Publication Date Title
JP6078211B2 (ja) 自閉症および自閉症の表現型に関連する遺伝子変化ならびに自閉症の診断および治療に対するその使用方法
JP4949240B2 (ja) 転写因子をコードするヒト自閉症素因遺伝子及びその使用
AU2006215385B2 (en) Uses of human autism susceptibility gene encoding a kinase
JP2008524999A (ja) 精神障害を治療するための組成物及び方法
EP1656458B1 (fr) Gene humain de susceptibilite a l'autisme et ses utilisations
JP2008504838A (ja) Ｐｒｋｃｂ１をコードするヒト自閉症感受性遺伝子およびその使用
JP2008537486A (ja) 膜貫通タンパク質をコード化するヒトの自閉症感受性遺伝子およびその使用
JP2008532499A (ja) 神経伝達物質輸送体をコードするヒトの自閉症感受性遺伝子及びその使用
JP2008525000A (ja) 統合失調症及び関連障害を治療するための組成物及び方法
JP2004508003A (ja) 一ヌクレオチド多型を含む核酸およびその使用方法
JP2006327951A (ja) 双極性感情障害、統合失調症等の精神病性障害の予防・治療剤、そのスクリーニング方法、及び該疾患の発症リスクの判定方法
US20150031569A1 (en) Mutations of the GPR179 Gene in Congenital Stationary Night Blindness
JP2008520233A (ja) カリウムイオンチャンネルをコードするヒト肥満感受性遺伝子及びその使用
Class et al. Patent application title: Mutations of the GPR179 Gene in Congenital Stationary Night Blindness Inventors: Christina Zeitz (Paris, FR) Isabelle Audo (Paris, FR) Elise Orhan (Paris, FR) Kinga Jakowska (Paris, FR) Jose Alain Sahel (Paris, FR)
WO2006003526A2 (fr) Gene humain de predisposition a l'autisme codant otoa et utilisations de celui-ci
JP2008502340A (ja) 味覚受容体をコードするヒト肥満感受性遺伝子及びその使用
WO2007101991A1 (fr) Cible pour l'amélioration d'une fonction cognitive

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090302

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111004

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20111215

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20111222

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120124

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120131

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120515